Nuaire Inc.

Nuaire Inc., a for-profit manufacturer of biomedical and microbiological laboratory equipment headquartered in Plymouth, Minnesota, supplies biosafety cabinets, laminar flow hoods, CO2 incubators, ultralow freezers, and related containment equipment to federal agencies as a prime contractor on full-and-open GSA schedule delivery orders with no predominant set-aside posture.

Nuaire operates almost exclusively as a prime contractor (100% of recent awards), delivering equipment through the General Services Administration's Multiple Award Schedule (MAS) vehicle, which anchors the vendor's federal footprint. Of 500 MAS task orders in the top parent vehicles block, the vendor places delivery orders through Federal Supply Schedule contracts GS25F5034C (323 task orders, $5.3 million) and GS24F0017N (297 task orders, $4.7 million), with the broader MAS program accounting for $16.2 million across 500 task orders. Equipment procurements span laboratory containment (biosafety cabinets in Class II Type A2, B1, and B2 configurations), specialized workstations (animal transfer stations, pharmacy isolators, laminar flow hoods), and supporting lab infrastructure (incubators, freezers, filters, and replacement components). Representative work includes a $1.95 million five-year purchase order from NIAID for eighteen Class II Type B1 biosafety cabinets with potential for up to 80 units total; $403.76 thousand from NIH Office of the Director for GSA schedule lab equipment; $403.76 thousand from CDC Pittsburgh for biosafety cabinets; and a $110 thousand procurement from West Point Military Academy for biosafety cabinets set aside for small business.

Customer concentration sits with civilian research agencies. The top five funding agencies by award count represent 18% of all awards: CDC Pittsburgh leads with 69 awards ($3.5 million combined potential value), followed by FDA (59 awards, $1.1 million), Navy Bureau of Medicine and Surgery (56 awards, $865 thousand), NIEHS (53 awards, $1.5 million), and CDC Office of Acquisition Services (51 awards, $1.2 million). The top five by dollar value cover 16% of combined potential value and include DOD Uniformed Services University ($3.5 million across 21 awards), CDC Pittsburgh ($3.5 million across 69 awards), NIAID ($3.1 million across 48 awards), NIEHS ($1.5 million across 53 awards), and CDC Acquisition Services ($1.2 million across 51 awards). Nuaire's 127 distinct customer agencies reflect broad civilian and defense reach, but the concentration on CDC, NIH institutes, FDA, and VA networks signals dominance in HHS and public health research procurement.

Activity has remained steady over five years—39 awards in 2022, 42 in 2023, 45 in 2024, 37 in 2025, and 12 recorded as of late September 2026—totaling 1,602 prime awards with $79.8 million combined potential value and $30.9 million in obligated dollars. Only five awards face completion and recompete within the next twenty-four months, carrying combined potential value of $169 thousand, indicating a low near-term recompete cliff. Set-aside activity scattered across the portfolio (Total Small Business designations recur on sporadic awards, roughly 20–25% of visible awards), but the vendor's core footprint flows through full-and-open MAS delivery orders with no SBA designation. The vendor's NAICS concentration reflects its manufacturing base: Analytical Laboratory Instrument Manufacturing (803 awards), Institutional Furniture Manufacturing (509 awards), with smaller exposure in industrial fan and blower equipment and surgical appliances. PSC coding aligns: Laboratory Equipment and Supplies (990 awards) dominates, followed by Medical and Surgical Instruments (254 awards) and Cabinets/Shelving (106 awards).

Nuaire subcontracts minimally—only two sub-awards appear in the source: a $2.1 million NIAID VRC operational task order under Weems Design Studio, Inc. (February 2025) for high-quality lab products and services, and a Roche Diagnostics sub-award (January 2024) for COVID-19 serology testing and biosafety cabinet support. This near-zero subcontract exposure and 100% prime posture indicate Nuaire operates as a direct equipment supplier rather than a systems integrator or teaming lead. The vendor holds an established General Services Administration Multiple Award Schedule contract registered since 2002, positioning it as a long-standing GSA schedule holder with recurring delivery order activity across federal civilian health, research, and defense medical organizations.